Cell biology of glioblastoma multiforme: from basic science to diagnosis and treatment

[1]  G. Stoyanov,et al.  On the Concepts and History of Glioblastoma Multiforme - Morphology, Genetics and Epigenetics , 2018, Folia medica.

[2]  G. Stoyanov,et al.  The Diagnostic Dilemma of Epithelial Marker Expression in Glioblastoma , 2019, Pathology & Oncology Research.

[3]  F. Adami,et al.  Glucose variations and their impact on the treatment response in advanced colorectal cancer , 2017 .

[4]  A. Tonchev,et al.  Demographics and Incidence of Histologically Confirmed Intracranial Tumors: A Five-year, Two-center Prospective Study , 2017, Cureus.

[5]  O. Adewale,et al.  Biology of glucose metabolization in cancer cells , 2017 .

[6]  Martina Kitanova,et al.  Correlation Between Ki-67 Index, World Health Organization Grade and Patient Survival in Glial Tumors With Astrocytic Differentiation , 2017, Cureus.

[7]  F. Adami,et al.  Central nervous system tumours profile at a referral center in the Brazilian Amazon region, 1997–2014 , 2017, PloS one.

[8]  S. Hamacher,et al.  A Retrospective Analysis of Ki-67 Index and its Prognostic Significance in Over 800 Primary Breast Cancer Cases. , 2017, Anticancer research.

[9]  G. Stoyanov,et al.  Cytokeratin AE1/AE3 mimicry in Glioblastoma , 2017 .

[10]  G. Stoyanov,et al.  THE GREAT IMITATOR – EMA POSITIVE GLIOBLASTOMA MULTIFORME , 2017 .

[11]  Effect of Ki-67 assessment in the distribution of breast cancer subtypes: Evaluation in a cohort of Latin American patients , 2017, Molecular and clinical oncology.

[12]  Ligang Chen,et al.  The effect of miR-21 on SWOZ2 glioma cells and its biological mechanism. , 2017, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[13]  N. Hay,et al.  Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy? , 2016, Nature Reviews Cancer.

[14]  Penggao Dai,et al.  Identification of MGMT promoter methylation sites correlating with gene expression and IDH1 mutation in gliomas , 2016, Tumor Biology.

[15]  G. Reifenberger,et al.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.

[16]  V. Beneš,et al.  IDH1/2 Mutation and MGMT Promoter Methylation - the Relevant Survival Predictors in Czech Patients with Brain Gliomas. , 2016, Folia biologica.

[17]  T. Jiang,et al.  IDH mutation and MGMT promoter methylation in glioblastoma: results of a prospective registry , 2015, Oncotarget.

[18]  Kimberly J. Johnson,et al.  Racial/Ethnic Differences in Pediatric Brain Tumor Diagnoses in Patients with Neurofibromatosis Type 1. , 2015, The Journal of pediatrics.

[19]  A. Órfão,et al.  Molecular and Genomic Alterations in Glioblastoma Multiforme. , 2015, The American journal of pathology.

[20]  Joshua B. Rubin,et al.  An integrative view on sex differences in brain tumors , 2015, Cellular and Molecular Life Sciences.

[21]  M. Mano,et al.  MicroRNAs in glioblastoma: role in pathogenesis and opportunities for targeted therapies. , 2015, CNS & neurological disorders drug targets.

[22]  Aaron A. Cohen-Gadol,et al.  Glioblastoma stem cells (GSCs) epigenetic plasticity and interconversion between differentiated non-GSCs and GSCs , 2015, Genes & diseases.

[23]  R. Ferner,et al.  Neurofibromatosis-related tumors: emerging biology and therapies , 2015, Current opinion in pediatrics.

[24]  A. Kong,et al.  Current Perspectives on Epigenetic Modifications by Dietary Chemopreventive and Herbal Phytochemicals , 2015, Current Pharmacology Reports.

[25]  T. Terada.  Expression of Cytokeratins in Glioblastoma Multiforme , 2015, Pathology & Oncology Research.

[26]  S. Paek,et al.  C-MET overexpression and amplification in gliomas. , 2015, International journal of clinical and experimental pathology.

[27]  R. Kaneva,et al.  IDH1/IDH2 but Not TP53 Mutations Predict Prognosis in Bulgarian Glioblastoma Patients , 2014, BioMed research international.

[28]  Aamir Ahmad,et al.  The Therapeutic Role of MicroRNAs in Human Gliomas , 2014 .

[29]  F. Sarkar.  MicroRNA Targeted Cancer Therapy , 2014, Springer International Publishing.

[30]  J. Barnholtz-Sloan,et al.  CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. , 2012, Neuro-oncology.

[31]  M. Scherer.  Some comments on the paper: Hans‐Joachim Scherer (1906–1945), pioneer in glioma research , 2013, Brain pathology.

[32]  Mohammad Mohammadianpanah,et al.  Treatment outcome and prognostic factors of adult glioblastoma multiforme. , 2013, Journal of the Egyptian National Cancer Institute.

[33]  I. Pollack,et al.  LOH in the HLA Class I Region at 6p21 Is Associated with Shorter Survival in Newly Diagnosed Adult Glioblastoma , 2013, Clinical Cancer Research.

[34]  Deric M. Park,et al.  Hes3 regulates cell number in cultures from glioblastoma multiforme with stem cell characteristics , 2013, Scientific Reports.

[35]  A. Veerman,et al.  Myeloid Antigen Expression in Childhood Acute Lymphoblastic Leukemia and Its Relevance for Clinical Outcome in Indonesian ALL-2006 Protocol , 2012, Journal of oncology.

[36]  Sujit S. Prabhu,et al.  Butterfly glioblastomas: a retrospective review and qualitative assessment of outcomes , 2012, Journal of Neuro-Oncology.

[37]  R. Roesler,et al.  Glioma Revisited: From Neurogenesis and Cancer Stem Cells to the Epigenetic Regulation of the Niche , 2012, Journal of oncology.

[38]  R. Martínez.  Beyond Genetics in Glioma Pathways: The Ever-Increasing Crosstalk between Epigenomic and Genomic Events , 2012, Journal of signal transduction.

[39]  Amy H. Andreotti,et al.  In Vivo Consequences of Disrupting SH3-Mediated Interactions of the Inducible T-Cell Kinase , 2012, Journal of signal transduction.

[40]  J. King,et al.  Adult glioblastoma multiforme survival in the temozolomide era: A population‐based analysis of Surveillance, Epidemiology, and End Results registries , 2012, Cancer.

[41]  A. Rademaker,et al.  Metastatic glioblastoma: case presentations and a review of the literature , 2012, Journal of Neuro-Oncology.

[42]  L. Deangelis,et al.  Virchow 2011 or how to ID(H) human glioblastoma. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  Alberto Orfao,et al.  Detailed characterization of alterations of chromosomes 7, 9, and 10 in glioblastomas as assessed by single-nucleotide polymorphism arrays. , 2011, The Journal of molecular diagnostics : JMD.

[44]  Andreas von Deimling,et al.  Prognostic significance of IDH-1 and MGMT in patients with glioblastoma: One step forward, and one step back? , 2011, Radiation oncology.

[45]  Yong Li,et al.  Chinese Anti鄄 Cancer a Ssociation , 2022 .

[46]  C. Sarkar,et al.  Loss of heterozygosity on chromosome 10q in glioblastomas, and its association with other genetic alterations and survival in Indian patients. , 2011, Neurology India.

[47]  空閑 太亮.  Prevalence of copy-number neutral LOH in glioblastomas revealed by genomewide analysis of laser-microdissected tissues , 2011 .

[48]  Lei Shi,et al.  Reduction of miR-21 induces glioma cell apoptosis via activating caspase 9 and 3. , 2010, Oncology reports.

[49]  J. Hodgson,et al.  microRNAs in Gliomas: Small Regulators of a Big Problem , 2009, NeuroMolecular Medicine.

[50]  Y. Enchev,et al.  Radiation-induced gliomas following radiotherapy for craniopharyngiomas: A case report and review of the literature , 2009, Clinical Neurology and Neurosurgery.

[51]  Lesley A. Mathews,et al.  Epigenetic gene regulation in stem cells and correlation to cancer. , 2009, Differentiation; research in biological diversity.

[52]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[53]  A. Agrawal.  Butterfly glioma of the corpus callosum. , 2009, Journal of cancer research and therapeutics.

[54]  Alexei Verkhratsky,et al.  Neuroglia: the 150 years after , 2008, Trends in Neurosciences.

[55]  C. Altaner,et al.  Glioblastoma and stem cells. , 2008, Neoplasma.

[56]  Č. Altaner.  Glioblastoma and stem cells Minireview , 2008 .

[57]  Gabriele Schackert,et al.  Long-term survival with glioblastoma multiforme. , 2007, Brain : a journal of neurology.

[58]  I. Shih,et al.  NAC-1 controls cell growth and survival by repressing transcription of Gadd45GIP1, a candidate tumor suppressor. , 2007, Cancer research.

[59]  B. Scheithauer,et al.  The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.

[60]  S. Chatterjee,et al.  Expression of cytokeratins in gliomas. , 2007, Indian journal of pathology & microbiology.

[61]  P. Kleihues,et al.  Genetic pathways to primary and secondary glioblastoma. , 2007, The American journal of pathology.

[62]  W. Löscher,et al.  The Blood-Brain Barrier and Cancer: Transporters, Treatment, and Trojan Horses , 2007, Clinical Cancer Research.

[63]  D. Louis.  WHO classification of tumours of the central nervous system , 2007 .

[64]  K. Black,et al.  Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma , 2006, Molecular Cancer.

[65]  S. Vandenberg,et al.  PDGFRα-Positive B Cells Are Neural Stem Cells in the Adult SVZ that Form Glioma-like Growths in Response to Increased PDGF Signaling , 2006, Neuron.

[66]  H. Mehdorn,et al.  Glioblastoma multiforme-report of 267 cases treated at a single institution. , 2005, Surgical neurology.

[67]  Shin Jung,et al.  Copyright � The Korean Academy of Medical Sciences Metastatic Glioblastoma in Cervical Lymph Node after Repeated Craniotomies: Report of a Case with Diagnosis by Fine Needle Aspiration , 2003 .

[68]  J. Abdullah,et al.  Loss of heterozygosity on chromosomes 10q, 9p, 17p and 13q in Malays with malignant glioma , 2004, Neurological research.

[69]  G. Sutherland,et al.  High levels of gelatinase-B and active gelatinase-A in metastatic glioblastoma , 2004, Journal of Neuro-Oncology.

[70]  J. Sabourin,et al.  Glioblastome péritonéal : récidive d'un tératome immature de l'ovaire : (à propos d'un cas) , 2002 .

[71]  J. Sabourin,et al.  [Peritoneal glioblastoma: recurrence of ovarian immature teratoma (report of a case)]. , 2002, Annales de pathologie.

[72]  Y. Yonekawa,et al.  Loss of Heterozygosity on Chromosome 19 in Secondary Glioblastomas , 2000, Journal of neuropathology and experimental neurology.

[73]  Stefano Colella,et al.  Loss of Heterozygosity on Chromosome 10 Is More Extensive in Primary (De Novo) Than in Secondary Glioblastomas , 2000, Laboratory Investigation.

[74]  R. Prayson,et al.  Evaluation of epithelial and keratin markers in glioblastoma multiforme: an immunohistochemical study. , 1999, Archives of pathology & laboratory medicine.

[75]  C. Sainte-Rose,et al.  Glioblastoma multiforme in a mature ovarian teratoma with recurring brain tumours , 1999, Histopathology.

[76]  P. Kleihues,et al.  Hans‐Joachim Scherer (1906‐1945), Pioneer in Glioma Research , 1999, Brain pathology.

[77]  L. Recht,et al.  Ki-67 (clone MIB-1) proliferation index in recurrent glial neoplasms: no prognostic significance. , 1998, Surgical neurology.

[78]  J. Moskal,et al.  Keratin expression in astrocytomas: an immunofluorescent and biochemical reassessment , 1997, Virchows Archiv.

[79]  R. GonzálezCámpora,et al.  Metastatic glioblastoma multiforme in cervical lymph nodes : report of a case with diagnosis by fine needle aspiration , 1993 .

[80]  Keratin intermediate filament expression in astrocytic neoplasms: analysis by immunocytochemistry, western blot, and northern hybridization. , 1993, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[81]  R. González Cámpora,et al.  Metastatic glioblastoma multiforme in cervical lymph nodes. Report of a case with diagnosis by fine needle aspiration. , 1993, Acta cytologica.

[82]  G. Wolf,et al.  Cervical metastatic glioblastoma multiforme. , 1992, Archives of otolaryngology--head & neck surgery.

[83]  P. Knott,et al.  Prenatal diagnosis of fetal glioblastoma multiforme , 1989, Prenatal diagnosis.

[84]  R. Virchow,et al.  Cellular Pathology, as Based upon Physiological and Pathological Histology , 1860, Nutrition reviews.

[85]  P. Kleihues,et al.  Ki-67 immunoperoxidase stain as marker for the histological grading of nervous system tumours. , 1988, Acta neurochirurgica. Supplementum.

[86]  P. Stern,et al.  Cloned human teratoma cells differentiate into neuron-like cells and other cell types in retinoic acid. , 1984, Journal of cell science.

[87]  F. Nogales,et al.  Neural Tissues in Human Teratomas , 1983 .

[88]  H. Scherer.  A CRITICAL REVIEW , 1940, Journal of neurology and psychiatry.